FDA CMC regulations and guidance simplified through examination, real life experiences and risk-based advice. This podcast hopes to educate sponsors and individuals on agency related regulatory CMC matters. We will focus on the critical CMC issues and build programs that enhance drug development. CMC topics will include Regulatory Starting Materials, API and Drug Product Process, Formulation Development, Supply Chains, Analytical Controls. Advocating and interpreting CMC Strategy, directing CMC Operations and Quality Assurance oversight in conjunction with developing CMC submission content that represents the best interests of emerging biotech. NOT INTENDED TO BE PRESCRIPTIVE ADVICE BUT RATHER INTERPRETATION THAT IS RIGHT FOR YOU. Since 2007 we have provided our partners with innovative strategies and exceptional advice intended to enhance program development, product approval, and marketing presence.
27 episodes
Episodes
025 - The Parenteral Drug Association & Evolution of Drug Development with Michael Carroll
00:31:513/12/2021
024 - Quality Management Systems Explained!
00:38:593/5/2021
023 - A Broadway Performance Analogy for API Process Validations with Jim Mencel
00:43:532/26/2021
022 - Filter Validation & How It Impacts Getting Your Product to Market with Shelli Connelly
00:32:102/19/2021
021 - Regulatory Odd Couple with Ed Narke & Meranda Parascandola
01:00:182/12/2021
020 - Lessons Gleaned from Twenty Five Years of a Regulatory CMC Life with Ed Narke
00:48:131/29/2021
019 - Complexity of Project Management in Drug Development with Paul Long
00:43:171/22/2021
018 - 2020: A Year in Review with Ed Narke, Brian Lihou & Meranda Parascandola
00:52:381/8/2021
017 - 4 Experts, 120+ Years of Drug Substance Experience: Major Trends You Should Know
00:34:3012/4/2020
016 - Brexit: What You Need to Know for Drug Development